[Investigation of ganciclovir resistance in CMV UL54 and UL97 gene regions in immunocompromised patients receiving gancyclovir treatment].
In conclusion, mutations responsible for GCV resistance was detected in 6.6% (2/30) of immunocompromised patients receiving GCV, indicating that the determination of CMV antiviral drug resistance may help clinicians for planning the antiviral therapy.
PMID: 26313280 [PubMed - in process]
Source: Mikrobiyoloji Bulteni - Category: Microbiology Tags: Mikrobiyol Bul Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Antiviral Therapy | Bone Marrow Transplant | Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Cytomegalovirus | Genetics | Hematology | Hodgkin's Disease | Leukemia | Lung Cancer | Lung Transplant | Lymphoma | Microbiology | Non-Hodgkin's Lymphoma | Study | Transplant Surgery | Transplants